Insulet (PODD)

• Market cap: $15.5B
• 1 day: -6.88%
• 5 days: -6.36%
• 1 month: -9.43%
• 3 months: -24.59%
• 6 months: -35.4%
• Year to date: -22.3%
• 1 year: -10.15%
• 5 years: -18.44%
• 10 years: 601.69%
• Sector: Healthcare
• Industry: Medical Devices

About: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Employees: 5,400